Beta Bionics (BBNX) vs PROCEPT BioRobotics (PRCT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Beta Bionics (BBNX) has outperformed PROCEPT BioRobotics (PRCT) over the past year, losing 18.4% versus a loss of 48.3%. PROCEPT BioRobotics is the larger company by market cap ($1.02 billion vs $975.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BBNX | PRCT |
|---|---|---|
| Share price | $18.08 | $17.91 |
| Market cap | $975.35M | $1.02B |
| 1-day change | -2.95% | +2.28% |
| YTD return | -40.66% | -43.07% |
| 1-year return | -18.37% | -48.25% |
| 5-year return | — | -58.89% |
| EPS (TTM) | $-1.64 | $-1.98 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $32.71 | $38.11 |
| 52-week low | $8.80 | $16.67 |
| Distance from 52-week high | -44.73% | -53.00% |
| Analyst consensus | buy | hold |
| Avg. price target upside | +31.64% | +25.18% |
| Average volume | 1.29M | 1.45M |
| Shares outstanding | 53.95M | 56.92M |
| Employees | 420 | 888 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BBNX has outperformed PRCT by 29.9 percentage points over the past year.
About Beta Bionics
BBNX stock →Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older.
Healthcare · Medical Devices · 420 employees
About PROCEPT BioRobotics
PRCT stock →PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia.
Healthcare · Medical Devices · 888 employees
BBNX vs PRCT FAQ
Which is bigger, Beta Bionics or PROCEPT BioRobotics?
PROCEPT BioRobotics (PRCT) is larger, with a market capitalization of $1.02B compared with $975.35M for Beta Bionics (BBNX).
Which stock has performed better over the past year, BBNX or PRCT?
BBNX returned -18.37% over the past 12 months, compared with -48.25% for PRCT (price return, excluding dividends). Past performance does not predict future results.
Are Beta Bionics and PROCEPT BioRobotics in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.